Quest Diagnostics (DGX) Invested Capital (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Invested Capital data on file, last reported at $8.2 billion in Q1 2026.

• Quarterly Invested Capital rose 13.82% year-over-year to $8.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.2 billion (up 13.82% YoY) and the FY2025 annual result came in at $12.8 billion, down 1.45% from the prior year.
• Invested Capital slipped to $8.2 billion in Q1 2026 per DGX's latest filing, from $12.8 billion in the prior quarter.
• The five-year high for Invested Capital was $13.1 billion in Q3 2024, with the low at $6.1 billion in Q1 2023.
• Average Invested Capital over 5 years is $8.5 billion, with a median of $7.4 billion recorded in 2024.
• Year-over-year, Invested Capital jumped 93.47% in 2024 and tumbled 40.71% in 2025.
• Quest Diagnostics' Invested Capital stood at $9.9 billion in 2022, then gained by 11.55% to $11.1 billion in 2023, then increased by 17.87% to $13.0 billion in 2024, then retreated by 1.45% to $12.8 billion in 2025, then tumbled by 36.38% to $8.2 billion in 2026.
• Business Quant data shows DGX's Invested Capital at $8.2 billion in Q1 2026, $12.8 billion in Q4 2025, and $7.8 billion in Q3 2025.